Literature DB >> 952979

Rat intestinal glycolipids. II. Distribution and biosynthesis of glycolipids and ceramide in villus and crypt cells.

J F Bouhours, R M Glickman.   

Abstract

Intestinal epithelial cells were isolated from rat intestine and grouped into villus and crypt cell fractions. Glycolipids were purified from each cell fraction and quantitated by fluorimetric determination of glycolipid sphingosine. Significant quantities of ceramide were found in all cell fractions and accounted for approximately 15% of total glycolipid sphingosine. While villus and crypt cell fractions quantitatively contained differing amounts of sphingosine, all cell fractions contained proportionally similar quantities of sphingosine when compared to cellular cholesterol or phospholipid. Individual glycolipids, however, showed significant differences in distribution between villus and crypt cells. Hematoside and glucosylceramide were proportionally increased in villus cells, while crypt cells showed an increase in trihexosylceramide and ceramide content. The rate of UDPglucose : hydroxy fatty acid ceramide glucosyltransferase was higher in villus cells while the rate of UDPgalactose : lactosylceramide galactosyltransferase was 3--4 times increased in crypt cells. These studies demonstrate that significant differences in both the distribution and biosynthesis of individual glycolipids occur in crypt and villus cells of rat intestine and are of possible importance in the process of intestinal cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 952979     DOI: 10.1016/0005-2760(76)90287-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Ganglioside epitope recognized by K99 fimbriae from enterotoxigenic Escherichia coli.

Authors:  E Ono; K Abe; M Nakazawa; M Naiki
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Two novel isoneolacto-undecaglycosylceramides carrying Galalpha1-->3Lewis(x) on the 6-linked antenna and N-acetylneuraminic acidalpha2-->3 or Galactose alpha1-->3 on the 3-linked antenna, expressed in porcine kidney.

Authors:  D Bouhours; J Liaigre; J Lemoine; F Mayer-Posner; J F Bouhours
Journal:  Glycoconj J       Date:  1998-10       Impact factor: 2.916

3.  Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation.

Authors:  C R Boland; C K Montgomery; Y S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

4.  Genetic control in the susceptibility of germfree inbred mice to infection by Escherichia coli O115a,c:K(B).

Authors:  K Itoh; T Matsui; K Tsuji; T Mitsuoka; K Ueda
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

5.  Premalignant alterations in the glycosphingolipids of small intestinal mucosa of rats treated with 1,2-dimethylhydrazine.

Authors:  R Dahiya; P K Dudeja; T A Brasitus
Journal:  Lipids       Date:  1988-05       Impact factor: 1.880

6.  In vitro model of attachment of Giardia intestinalis trophozoites to IEC-6 cells, an intestinal cell line.

Authors:  R E McCabe; G S Yu; C Conteas; P R Morrill; B McMorrow
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

7.  Dexamethasone influences the lipid fluidity, lipid composition and glycosphingolipid glycosyltransferase activities of rat proximal-small-intestinal Golgi membranes.

Authors:  P K Dudeja; R Dahiya; M D Brown; T A Brasitus
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

8.  Distribution of glycosphingolipids and ceramide of rat small intestinal mucosa.

Authors:  R Dahiya; T A Brasitus
Journal:  Lipids       Date:  1986-02       Impact factor: 1.880

9.  Distribution of glycosphingolipids of monkey small and large intestinal mucosa.

Authors:  R Dahiya; M D Brown; T A Brasitus
Journal:  Lipids       Date:  1986-02       Impact factor: 1.880

10.  Glycosphingolipids of fetal and adult sheep colonic mucosa.

Authors:  R Dahiya; T A Brasitus
Journal:  Lipids       Date:  1985-06       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.